BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15801848)

  • 1. Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer.
    Gududuru V; Hurh E; Dalton JT; Miller DD
    J Med Chem; 2005 Apr; 48(7):2584-8. PubMed ID: 15801848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer.
    Gududuru V; Hurh E; Dalton JT; Miller DD
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR studies of 2-arylthiazolidine-4-carboxylic acid amides: a novel class of cytotoxic agents for prostate cancer.
    Gududuru V; Hurh E; Sullivan J; Dalton JT; Miller DD
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4010-3. PubMed ID: 16005217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
    Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
    Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cells.
    Palchaudhuri R; Hergenrother PJ
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5888-91. PubMed ID: 18710803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel cytotoxic phospholipids for prostate cancer.
    Gududuru V; Hurh E; Durgam GG; Hong SS; Sardar VM; Xu H; Dalton JT; Miller DD
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4919-23. PubMed ID: 15341952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor activity of substituted triazolo[4,3-a]pyrimidin-6-sulfonamide with an incorporated thiazolidinone moiety.
    Hafez HN; El-Gazzar AR
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4143-7. PubMed ID: 19540114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies of arylthiazolidine amides as selective cytotoxic agents for melanoma.
    Li W; Wang Z; Gududuru V; Zbytek B; Slominski AT; Dalton JT; Miller DD
    Anticancer Res; 2007; 27(2):883-8. PubMed ID: 17465215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents.
    Kumar V; Mudgal MM; Rani N; Jha A; Jaggi M; Singh AT; Sanna VK; Singh P; Sharma PK; Irchhaiya R; Burman AC
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):763-70. PubMed ID: 18720190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-15 thiazol-4-yl analogues of (E)-9,10-didehydroepothilone D: synthesis and cytotoxicity.
    Hearn BR; Zhang D; Li Y; Myles DC
    Org Lett; 2006 Jul; 8(14):3057-9. PubMed ID: 16805551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity of 3-(5-phenyl-3H-[1,2,4]dithiazol-3-yl)chromen-4-ones and 4-oxo-4H-chromene-3-carbothioic acid N-phenylamides.
    Raj T; Bhatia RK; Kapur A; Sharma M; Saxena AK; Ishar MP
    Eur J Med Chem; 2010 Feb; 45(2):790-4. PubMed ID: 19939522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activities of 2-amino-thiazole-5-carboxylic acid phenylamide derivatives.
    Liu W; Zhou J; Qi F; Bensdorf K; Li Z; Zhang H; Qian H; Huang W; Cai X; Cao P; Wellner A; Gust R
    Arch Pharm (Weinheim); 2011 Jul; 344(7):451-8. PubMed ID: 21598297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone.
    Kung PP; Funk L; Meng J; Collins M; Zhou JZ; Johnson MC; Ekker A; Wang J; Mehta P; Yin MJ; Rodgers C; Davies JF; Bayman E; Smeal T; Maegley KA; Gehring MR
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6273-8. PubMed ID: 18929486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
    Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
    J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH; El-Gamal MI; Lee YS; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.
    Tsuzuki Y; Tomita K; Shibamori K; Sato Y; Kashimoto S; Chiba K
    J Med Chem; 2004 Apr; 47(8):2097-109. PubMed ID: 15056007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues.
    Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L; Radin NS; Shoemaker RH
    J Med Chem; 2008 Feb; 51(4):809-16. PubMed ID: 18251494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
    Jiang F; Weng Q; Sheng R; Xia Q; He Q; Yang B; Hu Y
    Arch Pharm (Weinheim); 2007 May; 340(5):258-63. PubMed ID: 17464965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
    Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimeric analogues of non-cationic tricyclic aromatic carboxamides are a new class of cytotoxic agents.
    Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    Anticancer Drug Des; 1999 Jun; 14(3):281-9. PubMed ID: 10500503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.